Lipitor, Atorvastatin Newswire (Page 3)

Lipitor, Atorvastatin Newswire (Page 3)

Comprehensive Real-Time News Feed for Lipitor, Atorvastatin (generic). (Page 3)

Results 41 - 60 of 1,059 in Lipitor, Atorvastatin (generic)

  1. Improving Assessment of Drug Safety Through Proteomics: Early...Read the original story

    Oct 3, 2017 | Circulation

    Early detection of adverse effects of novel therapies and understanding of their mechanisms could improve the safety and efficiency of drug development. We have retrospectively applied large-scale proteomics to blood samples from ILLUMINATE, a trial of torcetrapib , that involved 15,067 participants at high cardiovascular risk.

    Comment?

  2. Map: Who Will Save the Most with Generic LipitorRead the original story w/Photo

    Nov 30, 2011 | Kiplinger Online

    We plotted the cost of Lipitor in more than 300 cities to see who will benefit most from the drug's generic version. Pfizer lost its patent on the cholesterol-lowering drug Lipitor on November 30 -- which spells big savings for many of the 8.7 million Americans who take the medication.

    Comment?

  3. Use of non-vitamin K blood-thinners with certain medications...Read the original story w/Photo

    Oct 3, 2017 | PhysOrg Weblog

    Among patients with nonvalvular atrial fibrillation, concurrent use of certain commonly prescribed medications with non-vitamin K oral anticoagulants was associated with an increased risk of major bleeding, according to a study published by JAMA . Oral anticoagulation has been proven to prevent ischemic strokes and prolong life for patients with atrial fibrillation .

    Comment?

  4. Medicare patients face high costs for newer injected cholesterol drugsRead the original story w/Photo

    Sep 29, 2017 | Reuters

    Newer injected cholesterol medicines known as PCSK9 inhibitors can cost Medicare patients more than $300 a month, compared with only about $4 for older statin pills to lower cholesterol, a U.S. study suggests. Nationwide, approximately 9 million adults with heart disease and hardening of the arteries or a family history of dangerously high cholesterol don't succeed at lowering their cholesterol to healthy levels by taking statins, researchers note in JAMA Cardiology.

    Comment?

  5. Don't fall for these 6 Internet myths about statinsRead the original story w/Photo

    Sep 27, 2017 | Newkerala.com

    CHICAGO: Thanks to mailings and websites that claim statin medications are harmful or unnecessary, many patients are confused about whether they should take them. That's unfortunate, because the medication not only helps prevent heart attacks and strokes but also lowers the chance of developing peripheral arterial disease, or PAD, in which the arteries in the feet and legs become so narrow the tissues don't get enough oxygen.

    Comment?

  6. On Medicine : Can Heart Disease Shed Light on Cancer?Read the original story w/Photo

    Sep 27, 2017 | The New York Times

    Recently, I met a very unlucky man. A financial adviser in his mid-60s, he seemed chronically short of breath, and he had an odd habit of widening his eyes and raising his brows every time he finished a sentence.

    Comment?

  7. US Statins Market Growth, Demand, Forecast to 2022, Market Research ReportRead the original story w/Photo

    Sep 26, 2017 | SBWire

    Geographically, this report splits the United States market into seven regions: The West Southwest The Middle Atlantic New England The South The Midwest with sales , revenue , market share and growth rate of Statins in these regions, from 2012 to 2022 .

    Comment?

  8. STADA Arzneimittel AG (SAZ) Given Consensus Rating of "Sell" by BrokeragesRead the original story w/Photo

    Sep 25, 2017 | AmericanBankingNews.com

    Shares of STADA Arzneimittel AG have been assigned an average recommendation of "Sell" from the six brokerages that are covering the firm, Marketbeat Ratings reports. Four equities research analysts have rated the stock with a sell rating and two have issued a hold rating on the company.

    Comment?

  9. Analysts' Recent Ratings Changes for Intercept PharmaceuticalsRead the original story w/Photo

    Sep 21, 2017 | AmericanBankingNews.com

    9/19/2017 - Intercept Pharmaceuticals had its "buy" rating reaffirmed by analysts at Citigroup Inc.. They now have a $150.00 price target on the stock.

    Comment?

  10. Madrigal Pharmaceuticals Announces Positive Outcome from Pre-Planned...Read the original story w/Photo

    Sep 19, 2017 | GlobeNewswire

    Madrigal Pharmaceuticals, Inc. today announced that the Company's independent Data Safety Monitoring Board held its second prespecified meeting to evaluate both the heterozygous familial hypercholesterolemia and non-alcoholic steatohepatitis Phase 2 clinical trials and recommended that both studies continue without protocol modifications. Madrigal also announced that the Phase 2 study of MGL-3196 for the treatment of HeFH, a severe genetic dyslipidemia that causes early onset cardiovascular disease, has enrolled 113 patients, thereby exceeding the target patient enrollment of 105 patients, and will continue enrollment for the next several days.

    Comment?

  11. Abstract P428: Internalization of Angiotensinogen is Coupled to...Read the original story

    Sep 14, 2017 | Circulation

    We previously reported that isolated proximal tubules internalize angiotensinogen ; labeled Aogen accumulated in the nuclear and mitochondrial fractions and was associated with increased oxidative stress. Aogen internalization in non-renal epithelial cell types is unknown, thus, we assessed Aogen uptake in human retinal ARP-19 cells.

    Comment?

  12. Achieving Low Cholesterol Levels Now Possible With Cholestifin DropsRead the original story w/Photo

    Sep 18, 2017 | PR-inside.com

    According to a new study, nearly nine in ten patients with high LDL cholesterol levels could improve their condition with oral-only treatment. A variety of medications are used to lower blood cholesterol levels and statins are the most recommended by physicians.

    Comment?

  13. Low Brain Cholesterol-Separating Fact from FictionRead the original story w/Photo

    Sep 17, 2017 | Psychology Today

    Where do you find the highest concentration of cholesterol in your whole body? In your BRAIN . The brain is cholesterol-rich on purpose-because it needs large amounts of cholesterol to function properly.

    Comment?

  14. Could statins reduce the risk of Alzheimer's?Read the original story w/Photo

    Dec 28, 2016 | Medical News Today

    Statins are well known for their cholesterol-lowering ability, which can help reduce the risk of cardiovascular disease. But according to a new study, statins may also have the potential to lower the risk of Alzheimer's disease.

    Comment?

  15. STADA Arzneimittel AG (SAZ) - Investment Analysts' Weekly Ratings UpdatesRead the original story w/Photo

    Sep 14, 2017 | IntersportsWire

    Several brokerages have updated their recommendations and price targets on shares of STADA Arzneimittel AG in the last few weeks: 9/5/2017 - STADA Arzneimittel AG was given a new 74.40 price target on by analysts at Warburg Research. They now have a "sell" rating on the stock.

    Comment?

  16. The difference between Asian and Western in the effect of LDL-C...Read the original story

    Sep 13, 2017 | CiteULike

    The difference between Asian and Western in the effect of LDL-C lowering therapy on coronary atherosclerotic plaque: a meta-analysis report. The different effects of LDL-C levels and statins therapy on coronary atherosclerotic plaque between Western and Asian remain to be settled.

    Comment?

  17. Effects of Different Types of Statins on Lipid Profile: A Perspective on Asians.Read the original story

    Sep 13, 2017 | CiteULike

    The present review aimed at reviewing the effects of different statins on lipid profile, particularly in Asians. PubMed searches were conducted using the keywords 'statin, effect, and lipid profile' from database inception through March 2016.

    Comment?

  18. Statins for hemodialysis patients with diabetes? Long-term follow-up...Read the original story

    Sep 13, 2017 | CiteULike

    To insert individual citation into a bibliography in a word-processor, select your preferred citation style below and drag-and-drop it into the document. The clinical benefits of statins in dialysis patients are unproven.

    Comment?

  19. Long-term effects following 4 years of randomized treatment with...Read the original story

    Sep 13, 2017 | CiteULike

    Long-term effects following 4 years of randomized treatment with atorvastatin in patients with type 2 diabetes mellitus on hemodialysis. To insert individual citation into a bibliography in a word-processor, select your preferred citation style below and drag-and-drop it into the document.

    Comment?

  20. What your heart does not likeRead the original story w/Photo

    Sep 10, 2017 | Rediff.com

    INTERHEART, a very significant global study answers why Indians are more prone to cardiovascular diseases such as heart attacks and brain strokes compared to their Western counterparts. While the adverse risk factors are smoking, bad cholesterol, high blood pressure, diabetes, abdominal obesity, mellitus and psycho-social stress, the protective risk factors are regular intake of fruits and vegetables, regular exercise and moderate alcohol consumption.

    Comment?